BlackRock Japan’s Biogen BIIB Stock Holding History

BlackRock Japan’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$89.5M	Buy	315,680 +5,837	+2%	+$1.73M	0.3%	76
2016 Q3	$97M	Buy	309,843 +7,753	+3%	+$2.3M	0.33%	66
2016 Q2	$73.1M	Sell	302,090 -1,741	-0.6%	-$459K	0.26%	86
2016 Q1	$79.1M	Sell	303,831 -21,192	-7%	-$5.6M	0.29%	73
2015 Q4	$99.6M	Buy	325,023 +4,089	+1%	+$1.17M	0.37%	60
2015 Q3	$93.7M	Buy	320,934 +23,615	+8%	+$7.8M	0.38%	60
2015 Q2	$120M	Buy	297,319 +11,232	+4%	+$4.51M	0.46%	48
2015 Q1	$121M	Sell	286,087 -32,563	-10%	-$12.8M	0.48%	46
2014 Q4	$108M	Buy	318,650 +36,797	+13%	+$11.9M	0.41%	52
2014 Q3	$93.2M	Buy	281,853 +24,842	+10%	+$8.19M	0.4%	51
2014 Q2	$81M	Sell	257,011 -26,462	-9%	-$7.96M	0.37%	60
2014 Q1	$86.7M	Buy	283,473 +10,681	+4%	+$3.39M	0.39%	55
2013 Q4	$76.3M	Sell	272,792 -5,937	-2%	-$1.54M	0.34%	65
2013 Q3	$67.1M	Sell	278,729 -31,063	-10%	-$6.95M	0.32%	67
2013 Q2	$66.7M	Buy	+309,792	New	+$66.2M	0.31%	73

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock Japan's BIIB Position: Q4 2016 in Review

BlackRock Japan increased its Biogen (BIIB) stake by 1.9% in Q4 2016, buying an estimated $1.73M and bringing the position to 315,680 shares worth $89.5M. The position accounts for 0.3% of the portfolio, ranked #76.

BlackRock Japan first reported a position in BIIB in Q2 2013 and has held it in 15 quarters since. The position peaked at $121M in Q1 2015. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

BlackRock Japan held 315,680 shares of Biogen worth $89.5M as of Q4 2016.
BlackRock Japan bought 5,837 Biogen shares in Q4 2016, an estimated $1.73M.
Biogen made up 0.3% of BlackRock Japan's portfolio in Q4 2016, its #76 holding.
BlackRock Japan first reported a position in Biogen in Q2 2013 and has held it in 15 quarters since.
BlackRock Japan's Biogen position peaked at $121M in Q1 2015.
1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.